Position in PMVP
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$447
-$925 QoQ
Shares Held
361
-67.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PMVP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. PMVP ranks #535 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in PMVP
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $447 | 361 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,372 | 1,098 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,171 | 1,551 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $129,648 | 122,310 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $165,987 | 152,283 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $415,948 | 275,464 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $266,509 | 178,866 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $137,542 | 84,903 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $227,160 | 133,624 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $396,390 | 127,868 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $882,200 | 143,681 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $611,720 | 97,719 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $427,601 | 89,644 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,474,175 | 284,388 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,426,154 | 119,845 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $4,991,917 | 350,310 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $3,935,208 | 189,011 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,977,750 | 128,907 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,861,931 | 96,038 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $36,960 | 1,082 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $425,563 | 12,939 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $155,374 | 2,526 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $20,270 | 571 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||